PressNovember 13, 2023 Red Light Holland Psilocybin Microdosing Capsules Aimed to Be Distributed in Emerging Markets Pass Four Month Stability Testing by C-CREST Laboratories in Montreal, Canada
PressNovember 13, 2023 The Virtual Trip Showcases Veterans Sessions from Psychedelic Science 2023 in Honor of Veterans Day
PressNovember 9, 2023 PSYC’s CEO to Moderate Panel at The Cannabis & Psychedelics Investment Summit Hosted by Kahner Global
PressNovember 9, 2023 Silo Pharma to Initiate Dose-Ranging Study of Novel Intranasal Therapeutic SPC-15 for the Treatment of PTSD
PressNovember 9, 2023 Algernon Pharmaceuticals Receives Japanese Patent Notice of Allowance for Treatment of NASH with Repirinast
PressNovember 6, 2023 Revive Therapeutics Enters into Worldwide Exclusive Agreement with Lawson Health Research Institute to Develop and Commercialize a Novel Long COVID Rapid Test
PressNovember 6, 2023 Sunstone Therapies Announces Start of First Study of Multiple Doses of Psilocybin in Treatment of Depression in Patients with Cancer
PressNovember 6, 2023 DEA Announces Major Increase to 2023 Production Quotas for Psilocybin, THC and Ibogaine
PressNovember 6, 2023 Red Light Holland Engages Dr. Taras Nahirny, as Advisor to Help with Distribution of Company Homogenized Psilocybin Microdosing Capsules
BlogNovember 3, 2023 Media Blames Magic Mushrooms for Pilot’s Attempt to Bring Down Plane Full of Passengers: What Really Happened?
PressNovember 3, 2023 Optimi Health Announces Third and Final Tranche of CAD $1,000,000 Secured for Debt Financing
PressNovember 3, 2023 Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements
PressNovember 2, 2023 Reset Pharma Receives Notice of Safe to Proceed from FDA for Investigational New Drug (IND) Application for Oral Psilocybin RSTP1000
PressNovember 2, 2023 Cybin Provides Corporate Update and Highlights Key Upcoming Milestones Across its Development Pipeline
